MeiraGTx Holdings plc (MGTX)
NASDAQ: MGTX · Real-Time Price · USD
10.15
-0.38 (-3.61%)
Apr 21, 2026, 9:43 AM EDT - Market open
MeiraGTx Holdings Employees
As of December 31, 2025, MeiraGTx Holdings had 403 total employees, including 400 full-time and 3 part-time employees. The number of employees increased by 22 or 5.77% compared to the previous year.
Employees
403
Change
22
Growth
5.77%
Revenue / Employee
$201,963
Profits / Employee
-$283,377
Market Cap
939.46M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 403 | 22 | 5.77% | 400 | 3 |
| Sep 30, 2025 | 409 | 20 | 5.14% | 409 | 0 |
| Jun 30, 2025 | 386 | -1 | -0.26% | 386 | 0 |
| Mar 31, 2025 | 372 | -30 | -7.46% | 372 | 0 |
| Dec 31, 2024 | 381 | -44 | -10.35% | 375 | 6 |
| Sep 30, 2024 | 389 | -18 | -4.42% | 389 | 0 |
| Jun 30, 2024 | 387 | -19 | -4.68% | 387 | 0 |
| Mar 31, 2024 | 402 | 25 | 6.63% | 402 | 0 |
| Dec 31, 2023 | 425 | 67 | 18.72% | 419 | 6 |
| Sep 30, 2023 | 407 | 46 | 12.74% | 407 | 0 |
| Jun 30, 2023 | 406 | 73 | 21.92% | 406 | 0 |
| Mar 31, 2023 | 377 | 62 | 19.68% | 377 | 0 |
| Dec 31, 2022 | 358 | 62 | 20.95% | 343 | 15 |
| Sep 30, 2022 | 361 | 90 | 33.21% | 361 | 0 |
| Jun 30, 2022 | 333 | 64 | 23.79% | 333 | 0 |
| Mar 31, 2022 | 315 | 82 | 35.19% | 315 | 0 |
| Dec 31, 2021 | 296 | 77 | 35.16% | 287 | 9 |
| Sep 30, 2021 | 271 | 65 | 31.55% | 271 | 0 |
| Jun 30, 2021 | 269 | 101 | 60.12% | 269 | 0 |
| Mar 31, 2021 | 233 | 61 | 35.47% | 233 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,300 |
| Maravai LifeSciences Holdings | 435 |
| Xencor | 260 |
| Geron | 258 |
| Omeros | 175 |
| Janux Therapeutics | 109 |
| Annexon | 96 |
| Alto Neuroscience | 68 |
MGTX News
- 4 days ago - Eli Lilly Partner MeiraGTx Regains Rights For Genetic Eye Disease Drug From Johnson & Johnson - Benzinga
- 5 days ago - MeiraGTx Announces Pricing of $100 Million Offering of Ordinary Shares - GlobeNewsWire
- 5 days ago - MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP) - GlobeNewsWire
- 5 days ago - MeiraGTx Announces Positive Three-year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Late Radiation-Induced Xerostomia - GlobeNewsWire
- 7 days ago - MeiraGTx to Present 3-Year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia on Thursday, April 16, 2026 - GlobeNewsWire
- 26 days ago - MeiraGTx Announces FDA Breakthrough Therapy Designation for AAV2-hAQP1 for the Treatment of Grade 2 and Grade 3 Radiation-Induced Xerostomia (RIX) and Reports Fourth Quarter and Full Year 2025 Financial and Operational Results - GlobeNewsWire
- 2 months ago - ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy - PRNewsWire
- 5 months ago - Graviton Bioscience to Present Selective ROCK2 Obesity Data at 8th Annual Evercore HealthCONx Conference - PRNewsWire